# Noah Auerhahn

> Noah Auerhahn is a company founder and operator based in the San Francisco Bay Area. He co-founded Extrabux with Jeff Nobbs while at USC, took a product leadership role following its acquisition by Ebates, and later co-founded Robin Healthcare, where he served as early CEO. He is now co-founder and CEO of Uncommon Therapeutics, a Y Combinator Winter 2025 company.

- **Role:** Co-founder and CEO at Uncommon Therapeutics
- **Organizations:** Extrabux, Ebates / Rakuten Rewards, Robin Healthcare, Uncommon Therapeutics
- **Education:** B.S., Business Entrepreneurship, University of Southern California, Marshall School of Business
- **Known for:** Co-founded Extrabux, subsequently acquired by Ebates in an acquisition announced in March 2014., Co-founded the company that won the 2008 USC Business Plan Competition., Member of USC Marshall’s winning team at the October 2008 Asian Business Case Competition.

## Career timeline

- **2006** — Co-founded Extrabux with USC classmate Jeff Nobbs.
- **2008** — Extrabux won the $25,000 first prize in the USC Business Plan Competition.
- **2008** — Won the Asian Business Case Competition in Singapore with USC teammates Suzy Ryoo, Michael Cochran, and Shaun Sakhrani.
- **2011** — According to co-founder Jeff Nobbs, Extrabux declined a $300,000 investment after deciding the investor relationship was unsuitable.
- **2014** — Ebates announced its acquisition of Extrabux; Auerhahn was assigned product innovation and development for its Chinese-language site.
- **2017** — Co-founded Robin Healthcare with Emilio Galan; served as early CEO.
- **2024** — Listed as founder and CEO of Uncommon Therapeutics in a Charles River summit program.
- **2025** — Uncommon Therapeutics participated in Y Combinator Winter 2025; Auerhahn is listed as co-founder and CEO.

## Achievements

- Co-founded Extrabux, subsequently acquired by Ebates in an acquisition announced in March 2014.
- Co-founded the company that won the 2008 USC Business Plan Competition.
- Member of USC Marshall’s winning team at the October 2008 Asian Business Case Competition.
- Co-founded Robin Healthcare and served as its early CEO.
- Co-founder and CEO of Y Combinator Winter 2025 company Uncommon Therapeutics.

## Latest updates

- **—** — In Winter 2025, Uncommon Therapeutics participated in Y Combinator’s Winter 2025 batch; the directory lists Auerhahn as co-founder and CEO.

## Links

- LinkedIn: https://www.linkedin.com/in/noahauerhahn/

---

Profile page: https://yespress.io/noah-auerhahn
Published by YesPress — https://yespress.io
Last updated: 2026-10-22